Literature DB >> 32690953

Vpu modulates DNA repair to suppress innate sensing and hyper-integration of HIV-1.

Lisa Wiesmüller1, Frank Kirchhoff2, Meta Volcic3,4, Konstantin M J Sparrer4, Lennart Koepke4, Dominik Hotter4, Daniel Sauter4, Christina M Stürzel4, Myriam Scherer5, Thomas Stamminger5, Thomas G Hofmann6,7, Nathalie J Arhel4,8.   

Abstract

To avoid innate sensing and immune control, human immunodeficiency virus type 1 (HIV-1) has to prevent the accumulation of viral complementary DNA species. Here, we show that the late HIV-1 accessory protein Vpu hijacks DNA repair mechanisms to promote degradation of nuclear viral cDNA in cells that are already productively infected. Vpu achieves this by interacting with RanBP2-RanGAP1*SUMO1-Ubc9 SUMO E3-ligase complexes at the nuclear pore to reprogramme promyelocytic leukaemia protein nuclear bodies and reduce SUMOylation of Bloom syndrome protein, unleashing end degradation of viral cDNA. Concomitantly, Vpu inhibits RAD52-mediated homologous repair of viral cDNA, preventing the generation of dead-end circular forms of single copies of the long terminal repeat and permitting sustained nucleolytic attack. Our results identify Vpu as a key modulator of the DNA repair machinery. We show that Bloom syndrome protein eliminates nuclear HIV-1 cDNA and thereby suppresses immune sensing and proviral hyper-integration. Therapeutic targeting of DNA repair may facilitate the induction of antiviral immunity and suppress proviral integration replenishing latent HIV reservoirs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32690953     DOI: 10.1038/s41564-020-0753-6

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  73 in total

Review 1.  HIV DNA integration.

Authors:  Robert Craigie; Frederic D Bushman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.

Authors:  Jinwoo Ahn; Thomas Vu; Zach Novince; Jennifer Guerrero-Santoro; Vesna Rapic-Otrin; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

3.  The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro.

Authors:  R A Katz; G Merkel; J Kulkosky; J Leis; A M Skalka
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

4.  Early cytoplasmic uncoating is associated with infectivity of HIV-1.

Authors:  João I Mamede; Gianguido C Cianci; Meegan R Anderson; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

5.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro.

Authors:  R Craigie; T Fujiwara; F Bushman
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

6.  Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.

Authors:  Bärbel Schröfelbauer; Qin Yu; Samantha G Zeitlin; Nathaniel R Landau
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1.

Authors:  Nan Yan; Ashton D Regalado-Magdos; Bart Stiggelbout; Min Ae Lee-Kirsch; Judy Lieberman
Journal:  Nat Immunol       Date:  2010-09-26       Impact factor: 25.606

Review 8.  DNA damage repair machinery and HIV escape from innate immune sensing.

Authors:  Christelle Brégnard; Monsef Benkirane; Nadine Laguette
Journal:  Front Microbiol       Date:  2014-04-22       Impact factor: 5.640

9.  HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins.

Authors:  Kasia Hrecka; Caili Hao; Ming-Chieh Shun; Sarabpreet Kaur; Selene K Swanson; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-22       Impact factor: 11.205

Review 10.  Interactions between HIV-1 and the cell-autonomous innate immune system.

Authors:  Greg J Towers; Mahdad Noursadeghi
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

View more
  5 in total

1.  N6-methyladenosine modification of the Aedes aegypti transcriptome and its alteration upon dengue virus infection in Aag2 cell line.

Authors:  Zhenkai Dai; Kayvan Etebari; Sassan Asgari
Journal:  Commun Biol       Date:  2022-06-20

2.  Workshop on RanBP2/Nup358 and acute necrotizing encephalopathy.

Authors:  Alexander F Palazzo; Jomon Joseph; Ming Lim; Kiran T Thakur
Journal:  Nucleus       Date:  2022-12       Impact factor: 4.590

3.  A Fibrinogen Alpha Fragment Mitigates Chemotherapy-Induced MLL Rearrangements.

Authors:  Julia Eberle; Rahel Stefanie Wiehe; Boris Gole; Liska Jule Mattis; Anja Palmer; Ludger Ständker; Wolf-Georg Forssmann; Jan Münch; J Christof M Gebhardt; Lisa Wiesmüller
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

4.  Sex-specific differences in DNA double-strand break repair of cycling human lymphocytes during aging.

Authors:  Melanie Rall-Scharpf; Thomas W P Friedl; Shahar Biechonski; Michael Denkinger; Michael Milyavsky; Lisa Wiesmüller
Journal:  Aging (Albany NY)       Date:  2021-09-10       Impact factor: 5.682

5.  IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.

Authors:  Caterina Prelli Bozzo; Rayhane Nchioua; Meta Volcic; Lennart Koepke; Jana Krüger; Desiree Schütz; Sandra Heller; Christina M Stürzel; Dorota Kmiec; Carina Conzelmann; Janis Müller; Fabian Zech; Elisabeth Braun; Rüdiger Groß; Lukas Wettstein; Tatjana Weil; Johanna Weiß; Federica Diofano; Armando A Rodríguez Alfonso; Sebastian Wiese; Daniel Sauter; Jan Münch; Christine Goffinet; Alberto Catanese; Michael Schön; Tobias M Boeckers; Steffen Stenger; Kei Sato; Steffen Just; Alexander Kleger; Konstantin M J Sparrer; Frank Kirchhoff
Journal:  Nat Commun       Date:  2021-07-28       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.